Bacteriophages are perhaps the most widely spread and diverse microorganisms in the biosphere, are ubiquitous in Nature, and can be found in all reservoirs populated by bacterial hosts such as sea water, the soil, and the intestines of animals. They have been used as antibacterial agents in the former Soviet Union and Eastern Europe for over 60 years as an alternative to antibiotics and are seen as a possible modern therapy against multi drug and antibiotic resistant strains of many bacteria (Wikipedia).

In 1915, British biologist Frederick Twort, discovered the small agents that infected and killed bacteria. He believed them to be either a stage in the life cycle of the bacterium, an enzyme produced by the bacteria themselves, or a virus that grew on and destroyed the bacteria. In 1917, Félix d’Hérelle (1) proved the agents to be a “bacteria eating” virus which he called a bacteriophage and showed that dysentery could be cured using bacteriophages derived from the dysentery bacillus. 

Bacteriophages replicate by injecting their nuclear contents (RNA or DNA) into the bacterium and then use the bacterial DNA to manufacture multiple copies of themselves. This action of bacteriophages is identical to what Dr. Günther Enderlein describe as the “sexual union” between spermits and higher forms of the endobiont (bacterial forms). Both the actions of bacteriophages and spermits are species specific and result in the destruction of bacteria and offer a way in which the health of the host can be restored (2). Enderlein was very aware of bacteriophages and their identical nature to his spermits.

Prior to the discovery of antibiotics, bacteriophages were used with considerable success in the treatment of bacterial infections, but their use was made redundant by the manufacture and subsequent use of antibiotics, however, since the recent advent of antibiotic resistant bacteria due to overuse of antibiotics in the medical system it could well be that bacteriophages may once again find themselves back in favour. Recent research has shown that bacteriophages have been used successfully to treat antibiotic-resistant infections, so this is now becoming a reality (3, 4, 5, 6).

For more information on this, and other information concerning Enderlein’s Theory of Disease and Sanum Therapy, check out our website www.drtrev.com and sign up for our Online course in Live and Coagulated Blood Microscopy.

References:

1. D’Herelle, F. Comptes rendus Acad. Sciences 165: 373 – 375.
2. Enderlein, G., (1925) ARCH vol 1, “Zur Kenntnis der verglichenden Morphologie der Vurusfirmen….”.
3. Sulakvelidze, A., et al (2001) Antimicrobial Agents and Chemotherapy 45 (3): 649 – 659.
4. Jado, I, et al (2003) J. Antimicrob Chemother 52 (6): 967 – 973.
5. Wright, A., et al (2009) Clin. Otolaryngology 34 (4): 349 – 357.
6. Matsuzaki, S., et al (2009) J. Infection and Chemotherapy 11 (5): 211 – 219.